PMID- 2239664 OWN - NLM STAT- MEDLINE DCOM- 19901204 LR - 20190626 IS - 0002-8703 (Print) IS - 0002-8703 (Linking) VI - 120 IP - 5 DP - 1990 Nov TI - ACE inhibition improves vagal reactivity in patients with heart failure. PG - 1120-9 AB - The deranged autonomic control of heart rate was studied in 34 patients with heart failure (New York Heart Association [NYHA] functional class II to III) by examining the carotid sinus baroreflex. The carotid sinus baroreceptors were stimulated by graded suction. The slope of the regression line between increases in cycle length and the degree of neck suction was taken as an index of baroreflex sensitivity. The reflex response is mediated by a selective increase of vagal efferent activity. Baroreflex sensitivity therefore represents a measure of vagal reactivity. Using multiple regression analysis, baroreflex sensitivity (BS) correlated positively to stroke volume index (SVI) and inversely to plasma renin activity (PRA) and to age: BS = 0.47 SVI - 0.38 PRA - 0.23 age + constant (r = 0.74; p less than 0.0005). In addition to digitalis and diuretics, angiotensin-converting enzyme (ACE) inhibitors (captopril or enalapril) were given to 16 patients for a mean of 17 +/- 3 days. The patients with hemodynamic improvement (group A) exhibited improved baroreflex sensitivity (1.4 +/- 0.4 to 3.6 +/- 1.2 msec/mm Hg; p less than 0.01). Baroreflex sensitivity remained unchanged (3.1 +/- 0.8 to 2.4 +/- 1.0 msec/mm Hg; n.s.) in the patients without hemodynamic improvement (group B). The increase in reflex sensitivity did not correlate with hemodynamic alterations. Baroreflex sensitivity during ACE inhibition (BSD) was only related to the baseline baroreflex sensitivity (BSB): BSD = 2.8 BSB - 0.46 (r = 0.84; p less than 0.005). In patients with heart failure, reflex bradycardia decreases with age and with PRA and increases with stroke volume. Chronic therapy with ACE inhibitors enhances vagal reactivity in patients with hemodynamic improvement. FAU - Osterziel, K J AU - Osterziel KJ AD - Department of Internal Medicine, Ruprecht-Karls-University, Heidleberg, W. Germany. FAU - Dietz, R AU - Dietz R FAU - Schmid, W AU - Schmid W FAU - Mikulaschek, K AU - Mikulaschek K FAU - Manthey, J AU - Manthey J FAU - Kubler, W AU - Kubler W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am Heart J JT - American heart journal JID - 0370465 RN - 0 (Angiotensin-Converting Enzyme Inhibitors) RN - 69PN84IO1A (Enalapril) RN - 9G64RSX1XD (Captopril) SB - IM CIN - Am Heart J. 1991 Dec;122(6):1792. PMID: 1957783 MH - Adult MH - Aged MH - Angiotensin-Converting Enzyme Inhibitors/*therapeutic use MH - Captopril/therapeutic use MH - Cardiomyopathy, Dilated/drug therapy/*physiopathology MH - Carotid Sinus/drug effects/physiopathology MH - Coronary Disease/drug therapy/*physiopathology MH - Enalapril/therapeutic use MH - Female MH - Humans MH - Male MH - Middle Aged MH - Pressoreceptors/drug effects/physiopathology MH - Reflex/drug effects/physiology MH - Vagus Nerve/drug effects/*physiopathology EDAT- 1990/11/01 00:00 MHDA- 1990/11/01 00:01 CRDT- 1990/11/01 00:00 PHST- 1990/11/01 00:00 [pubmed] PHST- 1990/11/01 00:01 [medline] PHST- 1990/11/01 00:00 [entrez] AID - 0002-8703(90)90125-H [pii] AID - 10.1016/0002-8703(90)90125-h [doi] PST - ppublish SO - Am Heart J. 1990 Nov;120(5):1120-9. doi: 10.1016/0002-8703(90)90125-h.